RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection
PLOS ONE · 23.08.2024 · 19 (8) · e0307450
DOI: 10.1371/journal.pone.0307450 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 23.08.2024. Verfasst von Molly Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Diego, La Jolla, California, United States of America. Hauptthemen laut MEDLINE: COVID-19, RNA Editing, Adenosine Deaminase, SARS-CoV-2. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCATS NIH HHS, National Science Foundation.
Abstract (Originalsprache)
Adenosine to inosine (A-to-I) RNA editing by ADAR1 has been implicated in maintaining self-tolerance, preventing autoimmunity, and mediating antiviral immunity. Foreign viral double-stranded RNA triggers rapid interferon response and activates ADAR1 in the host immune system. Emerging data points to a role of ADAR1 A-to-I editing in the inflammatory response associated with severe COVID-19 disease. We identify A-to-I editing events within human whole transcriptome data from SARS-CoV-2 infected individuals, non-infected individuals, and individuals with other viral illnesses from nasopharyngeal swabs. High levels of RNA editing in host cells are associated with low SARS-CoV-2 viral load (p = 9.27 E-06), suggesting an inhibitory effect of ADAR1 on viral infection. Additionally, we find differentially expressed genes associated with RNA-modifications and interferon response. Single cell RNA-sequencing analysis of SARS-CoV-2 infected nasopharyngeal swabs reveals that cytotoxic CD8 T cells upregulate ADAR1 in COVID-19 positive samples (p = 0.0269). We further reveal ADAR1 expression increases with CD4 and CD8 T cell activation, and knockdown of ADAR1 leads to apoptosis and aberrant IL-2 secretion. Together, our data suggests A-to-I RNA editing is required to maintain healthy homeostasis of activated T cells to combat SARS-CoV-2 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Diego, La Jolla, California, United States of America.
- Bioinformatics and Systems Biology Graduate Program, University of California San Diego, La Jolla, California, United States of America.
- Center for Computational Biology & Bioinformatics, University of California San Diego, La Jolla, California, United States of America.
- Division of Regenerative Medicine and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America.
- KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, California, United States of America.
- Blue Marble Space Institute of Science, Seattle, Washington, United States of America.
ORCID-Profile: Kathleen M Fisch
Förderung
- NCI NIH HHS
- NCATS NIH HHS
- National Science Foundation
- National Center for Advancing Translational Sciences
- National Cancer Institute
- Amazon Web Services
- San Diego Supercomputer Center
Zitieren
APA
Huang, M., Mark, A., Pham, J., Vera, K., Saravia-Butler, A. M., Beheshti, A., Jiang, Q., & Fisch, K. M. (2024). RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection. PLOS ONE, 19(8), e0307450. https://doi.org/10.1371/journal.pone.0307450
Vancouver
Huang M, Mark A, Pham J, Vera K, Saravia-Butler AM, Beheshti A, et al. RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection. PLOS ONE. 2024;19(8):e0307450. doi:10.1371/journal.pone.0307450
BibTeX
@article{Huang2024,
author = {Huang, Molly and Mark, Adam and Pham, Jessica and Vera, Karina and Saravia-Butler, Amanda M and Beheshti, Afshin and Jiang, Qingfei and Fisch, Kathleen M},
title = {RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {8},
pages = {e0307450},
doi = {10.1371/journal.pone.0307450}
}
EUVIMED